首页> 美国卫生研究院文献>Bulletin of the World Health Organization >A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa 1995.
【2h】

A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa 1995.

机译:可以预见的卷土重来:1995年非洲第二次脑膜炎奈瑟氏球菌A亚群血清感染引起的第二次大流行。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Between 14 January and 4 April 1995 we isolated and characterized 44 meningococcal strains in Cameroon, Chad, Niger, and Burkina Faso; among these was the strain A:4:P1.9/clone III-1, which was involved in the second meningitis pandemic. This isolate was found in the clonal form in Niger and strains of the ET-37 complex were also found in the other three study countries, but apparently did not cause epidemics. One strain (Y:2a:P1.2,5 (ET-37 complex)) was isolated in January 1995 and another (A:4:P1.9) in March 1995 in Garoua (Cameroon). Eight strains were isolated in Moundou (Chad) between January and April 1995: the A:4:P1.9/clone III-1 (1 strain); members of the ET-37 complex (Y:2a:P1.2,5 (4 strains), Y:NT:P1.2,5 (1 strain), and Y:2a:-(1 strain)); and serogroup X (1 strain). In Niger, 31 strains were isolated between February and April 1995 from different regions. All were A:4:P1.9/clone III-1; between November 1994 and April 1995 there were 23814 cases of meningitis reported of which 2227 resulted in death. Three strains were isolated in Burkina Faso in April 1995: two were Y:2a:P1.2,5 (ET-37 complex) and one was A:4:P1.9/clone III-1. Thus in 1995 the epidemic and invasive strain (A:4:P1.9/clone III-1) responsible for the second pandemic was present in the four countries (Cameroon, Chad, Niger and Burkino Faso) that make up the area frequently affected by such epidemics and where cases are generally reported during the dry season.
机译:在1995年1月14日至4月4日期间,我们在喀麦隆,乍得,尼日尔和布基纳法索分离并鉴定了44株脑膜炎球菌。其中包括菌株A:4:P1.9 /克隆III-1,该菌株参与了第二次脑膜炎大流行。在尼日尔发现了这种分离株的克隆形式,在其他三个研究国家也发现了ET-37复合株,但显然没有引起流行。 1995年1月分离了一种菌株(Y:2a:P1.2,5(ET-37复合物)),另一种菌株(A:4:P1.9)于1995年3月在加鲁阿(喀麦隆)分离到。在1995年1月至4月之间在蒙杜(乍得)分离了八株:A:4:P1.9 /克隆III-1(1株); A:4:P1.9 /克隆III-1(1株)。 ET-37复合物的成员(Y:2a:P1.2,5(4个菌株),Y:NT:P1.2,5(1个菌株)和Y:2a :-( 1个菌株));和血清群X(1株)。在尼日尔,1995年2月至4月之间从不同地区分离出31株。全部是A:4:P1.9 /克隆III-1;在1994年11月至1995年4月期间,报告了23814例脑膜炎病例,其中2227例死亡。 1995年4月在布基纳法索分离出三株菌株:两株为Y:2a:P1.2,5(ET-37复合物),一株为A:4:P1.9 /克隆III-1。因此,在1995年,造成第二次大流行的流行和侵入性毒株(A:4:P1.9 / clone III-1)在构成经常受影响地区的四个国家(喀麦隆,乍得,尼日尔和布基诺法索)出现由这种流行病引起的,以及通常在旱季报告的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号